| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/12/2012 | CA2811700A1 New treatments of hepatitis c virus infection |
| 04/12/2012 | CA2805387A1 Environmentally sensitive compositions |
| 04/11/2012 | EP2439270A1 Galactosidase derived from bacillus circulans |
| 04/11/2012 | EP2439209A1 Endokinin c/d-origin peptides |
| 04/11/2012 | EP2439204A1 Heterocyclic compound and hematopoietic stem cell amplifier |
| 04/11/2012 | EP2438927A1 Pharmaceutical composition, food or beverage, and methods for these products |
| 04/11/2012 | EP2438925A2 Compounds that modulate neuronal growth and their uses |
| 04/11/2012 | EP2438822A2 Neuroprotective dietary supplement |
| 04/11/2012 | EP2438170A2 Soga polynucleotides and polypeptides and uses thereof |
| 04/11/2012 | EP2438086A1 Improved reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c) |
| 04/11/2012 | EP2438085A1 Synthesis and use of radiolabelled insulin analogues |
| 04/11/2012 | EP2438083A1 Serum amyloid p derivatives and their preparation and use |
| 04/11/2012 | EP2437776A2 Relaxin peptide synthesis |
| 04/11/2012 | EP2437775A1 Fgf-21 for treating cancers |
| 04/11/2012 | EP2437773A1 Method for enhancing phagocytosis of phosphatidylserine-exposing cells |
| 04/11/2012 | EP2437772A1 Immunoregulatory peptides and methods of use |
| 04/11/2012 | EP2437771A2 Compositions and methods modulating mg29 for the treatment of diabetes |
| 04/11/2012 | EP2437770A2 Antimicrobial peptides |
| 04/11/2012 | EP2437769A2 Recombinant production of peptides |
| 04/11/2012 | EP2437768A2 Compounds and methods for treating bone disorders and controlling weight |
| 04/11/2012 | EP2437759A1 Method for cancer therapy based on co-administration of a parvovirus and a cytokine |
| 04/11/2012 | EP2437749A2 Interlaced method for treating cancer or a precancerous condition |
| 04/11/2012 | EP2437748A1 Combination preparations comprising a cytokine antagonist and corticosteroid |
| 04/11/2012 | EP2437747A1 Combination preparations comprising exosomes and corticosteroid |
| 04/11/2012 | EP2437728A2 Therapeutic ophthalmic emulsions |
| 04/11/2012 | EP2437727A2 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 04/11/2012 | EP2437722A1 Ophthalmic oil-in-water emulsions containing cyclosporine or a polyphenol |
| 04/11/2012 | EP1957082B1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 04/11/2012 | EP1948689B1 High activity growth factor mutants |
| 04/11/2012 | EP1907412B1 Peptides inhibiting angiotensin-converting enzyme |
| 04/11/2012 | EP1891105B1 Oxyntomodulin analogues and their effects on feeding behaviour |
| 04/11/2012 | EP1861121B1 Hiv vaccine composition |
| 04/11/2012 | EP1781377B1 Elastase inhibitor in leukemia |
| 04/11/2012 | EP1718767B1 Compositions for treating breast and pancreatic cancer |
| 04/11/2012 | EP1594964B1 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor |
| 04/11/2012 | EP1503794B1 Methods of treatement using ctla-4 antibodies |
| 04/11/2012 | EP1377596B1 Ttk in diagnosis and as a therapeutic target in cancer |
| 04/11/2012 | EP1341909B2 A method for in vitro molecular evolution of protein function |
| 04/11/2012 | EP1334120B1 Modified clostridial neurotoxins with altered biological persistence |
| 04/11/2012 | EP1326840B1 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/11/2012 | EP1320387B1 Pharmaceutical compositions for sustained delivery of peptides |
| 04/11/2012 | EP1235912B1 Tumour-specific vector for gene therapy |
| 04/11/2012 | EP1220870B1 Metal-binding compounds and uses therefor |
| 04/11/2012 | EP1194123B1 Method for controlled production of ultrafine microparticles and nanoparticles |
| 04/11/2012 | EP1125947B1 Human H37 protein and cDNA encoding the same |
| 04/11/2012 | CN1984926B Fsh糖基化突变体 Fsh glycosylation mutants |
| 04/11/2012 | CN102414224A Apparatus, system, and method for creating immunologically enhanced spaces in-vivo |
| 04/11/2012 | CN102413836A Treatment of diseases related to hyperactivity of the complement system |
| 04/11/2012 | CN102413835A 包含GnRH类似物的缓释制剂 Sustained-release formulations containing GnRH analogues |
| 04/11/2012 | CN102413826A 用于消除革兰氏阴性菌的组合物和方法 The compositions and methods for the elimination of Gram-negative bacteria |
| 04/11/2012 | CN102413759A Drug delivery management systems and methods |
| 04/11/2012 | CN102413716A Method for controlling the digestive coagulation of proteins |
| 04/11/2012 | CN102409056A 抑制血管生成相关基因序列 Inhibition of angiogenesis related gene sequences |
| 04/11/2012 | CN102409010A 一株γ-变形菌及其应用 A γ- Proteobacteria and Its Applications |
| 04/11/2012 | CN102408485A 血小板生成素模拟肽二联体与人血清白蛋白的融合蛋白及其制备方法和应用 Human serum albumin fusion thrombopoietin mimetic peptide two conjoined protein and its preparation method and application |
| 04/11/2012 | CN102408484A 具有wnk激酶抑制作用的重组穿膜肽及其应用 Recombinant kinase inhibition has wnk penetrating peptide and its application |
| 04/11/2012 | CN102408477A 鹿角脱盘蛋白多肽及其制备方法和应用 Antler disk polypeptides and its preparation method and application |
| 04/11/2012 | CN102408472A 一种Bt蛋白Cry62Aa1、其编码基因及应用 One kind of Bt protein Cry62Aa1, its coding gene and application |
| 04/11/2012 | CN102408470A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation |
| 04/11/2012 | CN102408469A Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/11/2012 | CN102406943A 人成纤维细胞生长因子-21的聚乙二醇化学修饰物及其制备方法 Polyethylene glycol chemically modified human adult material fibroblast growth factor-21 and its preparation method |
| 04/11/2012 | CN102406942A 一种制备纳豆激酶环糊精包合物的方法 A process for preparing cyclodextrin inclusion of nattokinase |
| 04/11/2012 | CN102406937A Novel cytokine zalpha11 ligand |
| 04/11/2012 | CN102406924A Medicine composition for treating cerebrovascular and cardiovascular diseases as well as preparation method and application thereof |
| 04/11/2012 | CN102406923A 三种能提高纳豆激酶活性的中药 Three Chinese medicine can increase the activity of nattokinase |
| 04/11/2012 | CN102406922A 兽用复方长效烟酸诺氟沙星混悬液及其制备方法 Long-acting niacin norfloxacin suspension veterinary compound and its preparation method |
| 04/11/2012 | CN102406921A Ghgkhknk八肽对5-氟尿嘧啶抗肿瘤增效作用的医药用途 Ghgkhknk octapeptide 5-fluorouracil synergistic anti-tumor medicinal use |
| 04/11/2012 | CN102406920A 一种可治疗脚臭的复合药物配方及其制作方法 One kind of odor compound to treat drug formulation and manufacturing method thereof |
| 04/11/2012 | CN102406601A 恩拉霉素溶液剂及其制备方法 Enramycin solution and its preparation method |
| 04/11/2012 | CN102405935A 鱼精蛋白复配制剂及其制备方法和应用 Protamine complex and its preparation method and application |
| 04/11/2012 | CN101541305B 用以处理口腔炎的包含表皮成长因子的稳定液体组成物 For treatment of stomatitis comprising a stable liquid composition of the epidermal growth factor |
| 04/11/2012 | CN101343640B 共表达CTLA4Ig和CTLA4的重组腺病毒载体、重组腺病毒及其应用 Co-expression of CTLA4Ig and CTLA4 recombinant adenovirus vector, recombinant adenovirus and its applications |
| 04/11/2012 | CN101309932B 新粘蛋白型糖蛋白及其应用 New mucin-type glycoprotein and its applications |
| 04/11/2012 | CN101260150B 犬钩虫抗凝肽及其制备和应用 Canine hookworm anticoagulant peptide and its preparation and application |
| 04/11/2012 | CN101193908B 有机化合物 Organic compounds |
| 04/11/2012 | CN101121751B Ptd-酪氨酸羟化酶催化区域融合蛋白及其应用 Ptd- tyrosine hydroxylase catalytic domain fusion protein and its application |
| 04/10/2012 | USRE43309 Immunoregulatory compositions |
| 04/10/2012 | US8153776 Using targeted gene expression inhibition to treat and prevent viral infection |
| 04/10/2012 | US8153775 Kits for detecting rank |
| 04/10/2012 | US8153773 Synthesis and use of anti-reverse phosphorothioate analogs of the messenger RNA cap |
| 04/10/2012 | US8153771 Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency |
| 04/10/2012 | US8153770 Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency |
| 04/10/2012 | US8153761 Microwave-assisted peptide synthesis |
| 04/10/2012 | US8153759 Depsipeptide containing lactic acid residue |
| 04/10/2012 | US8153683 Methods of treatment using a prodrug of an excitatory amino acid |
| 04/10/2012 | US8153631 Triazole compounds and uses related thereto |
| 04/10/2012 | US8153599 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 04/10/2012 | US8153598 PKD ligands and polynucleotides encoding PKD ligands |
| 04/10/2012 | US8153597 Modulators of the ABC transporter family and methods for their use |
| 04/10/2012 | US8153596 Use of SH2 STAT3/STAT1 peptidomimetics as anticancer drugs |
| 04/10/2012 | US8153595 B7-DC variants immunogenic compositions and methods of use thereof |
| 04/10/2012 | US8153594 Tacrolimus standard and methods of using same |
| 04/10/2012 | US8153593 Transglutaminase inhibitors and methods of use thereof |
| 04/10/2012 | US8153592 Modulating toll-like receptor activity |
| 04/10/2012 | US8153591 Protein biomaterials and biocoacervates and methods of making and using thereof |
| 04/10/2012 | US8153588 Methods useful in the treatment of bone resorption diseases |
| 04/10/2012 | US8153587 Orally administering parathyroid hormone and calcitonin |
| 04/10/2012 | US8153586 FGF homologs compositions and uses thereof |
| 04/10/2012 | US8153585 Peptide antagonists of vascular endothelial growth factor and methods of use thereof |
| 04/10/2012 | US8153584 Methods for promoting organ development |